Status:
COMPLETED
Effective Fraction of Inspired Oxygen With Nasal Cannula in Premature Infants
Lead Sponsor:
University of Miami
Conditions:
Oxygen Therapy
Eligibility:
All Genders
Brief Summary
The objective of this study is to determine the multifactorial relationship between the effective fraction of inspired oxygen (Effective-FiO2) and the FiO2 in the gas delivered by the nasal cannula (N...
Detailed Description
During routine nasal cannula (NC) use in the newborn ICU, the actual fraction of oxygen inspired by the infant, i.e. the effective FiO2 (Effective-FiO2) that reaches the infant's airways, cannot be ea...
Eligibility Criteria
Inclusion
- Premature infants born between 23 and 30 weeks of gestational age
- Receiving supplemental oxygen via nasal cannula
- Parental informed consent
Exclusion
- Major congenital anomalies
- Clinically unstable
Key Trial Info
Start Date :
April 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 7 2023
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03431818
Start Date
April 4 2018
End Date
September 7 2023
Last Update
March 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NICU at Holtz Children's Hospital
Miami, Florida, United States, 33136